Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population-based comparison
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (6) , 1335-1342
- https://doi.org/10.1016/0735-1097(96)00018-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Variation in Hospital Length of Stay for Acute Myocardial Infarction in Ontario, CanadaMedical Care, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarctionJournal of the American College of Cardiology, 1991
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985